Key Dates
- Board Meeting Date: Friday, July 24, 2026
- Trading Window Closure Period: Commenced July 1, 2026, will end 48 hours after declaration of Un-Audited Financial Results for quarter ended June 30, 2026
- Intimation Date: July 20, 2026
Agenda Items
The Board of Directors will consider:
1. Financial Results Approval: To consider, approve and take on record the un-audited standalone and consolidated financial results of the Company for the quarter ended on June 30, 2026.
2. Fundraising Proposal: To consider, evaluate and approve the proposal for raising of funds by way of issue of any instrument or security(ies) including:
- Equity shares
- Fully/partly convertible/non-convertible instruments including debenture warrants
- Warrants entitling the warrant holder(s) to apply for equity shares
- Any other equity based instruments
- Foreign currency convertible bonds
- Such other eligible securities
- Any combination thereof in one or more tranches
Fundraising Methods
The fundraising may be conducted through:
- Further public issue
- Qualified institution placements
- Preferential issue
- Private placement
- Any other permissible mode
- Any combination of the above methods
Regulatory Framework
The fundraising will be conducted in accordance with:
- Applicable provisions of the Companies Act 2013
- Securities and Exchange Board of India (Issue of Capital and Disclosure Requirement) Regulations, 2018 (ICDR Regulations)
- Subject to receipt of necessary approvals including approval of members of the Company at a general meeting or through postal ballot
- Subject to other regulatory/statutory approvals as may be required
Trading Window Closure
Pursuant to the company's intimation dated June 26, 2026, the trading window closure period has been in effect since July 1, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Document Availability
This intimation has been uploaded on the Company's website at https://neogenchem.com/financialperformance/.